Inventor · disambiguated record
William J. Sasiela
Also filed as: SASIELA WILLIAM · SASIELA WILLIAM J
7 granted patents·26 pending applications·67 citations·filing 2007–2025
86Inventor score
Files withREGENERON PHARMA15SANOFI BIOTECHNOLOGY8ESPERION THERAPEUTICS INC3AEGERION PHARMACEUTICALS INC2PRESSLER MILTON L2
Top patents by PatentIndex Score
33 records- 0194US9724411B2Methods for treating hypercholesterolemia and reducing LDL-C using antibodies to PCSK9REGENERON PHARMA·Filed 2013·Granted Aug 8, 2017·15 cites·32 claims
- 0291US11306155B2Methods for treating patients with heterozygous familial hypercholesterolemia (heFH) with an anti-PCSK9 antibodySANOFI BIOTECHNOLOGY·Filed 2019·Granted Apr 19, 2022·5 cites·14 claims
- 0391US10995150B2Methods for inhibiting atherosclerosis by administering an anti-PCSK9 antibodyREGENERON PHARMA·Filed 2019·Granted May 4, 2021·6 cites·19 claims
- 0488US10544232B2Methods for treating patients with heterozygous familial hypercholesterolemia (heFH) with an anti-PCSK9 antibodySANOFI BIOTECHNOLOGY·Filed 2015·Granted Jan 28, 2020·9 cites·16 claims
- 0588US10111953B2Methods for reducing remnant cholesterol and other lipoprotein fractions by administering an inhibitor of proprotein convertase subtilisin kexin-9 (PCSK9)REGENERON PHARMA·Filed 2014·Granted Oct 30, 2018·15 cites·12 claims
- 0685US10494442B2Methods for inhibiting atherosclerosis by administering an inhibitor of PCSK9REGENERON PHARMA·Filed 2014·Granted Dec 3, 2019·9 cites·20 claims
- 0784US10428157B2Dosing regimens for use with PCSK9 inhibitorsSANOFI BIOTECHNOLOGY·Filed 2014·Granted Oct 1, 2019·8 cites·13 claims
- 0882US2025332254A1Methods for treating patients with familial hypercholesterolemiaREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 0982US2025059300A1METHODS FOR TREATING PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (heFH) WITH AN ANTI-PCSK9 ANTIBODYSANOFI BIOTECHNOLOGY·Filed 2024·Application pending·0 cites
- 1074US2023000976A1Methods for treating patients with familial hypercholesterolemiaREGENERON PHARMA·Filed 2022·Application pending·0 cites
- 1173US2022315669A1METHODS FOR TREATING PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (heFH) WITH AN ANTI-PCSK9 ANTIBODYSANOFI BIOTECHNOLOGY·Filed 2022·Application pending·0 cites
- 1264US2024226049A1Methods of treatment using bempedoic acidESPERION THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1362US2024226048A1Methods of treatment using bempedoic acidESPERION THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1462US2013064834A1Methods for treating hypercholesterolemia using antibodies to pcsk9REGENERON PHARMA·Filed 2012·Application pending·0 cites
- 1561US2019330371A1Methods for Treating Autosomal Dominant Hypercholesterolemia Associated with PCSK9 Gain-Of-Function MutationsREGENERON PHARMA·Filed 2019·Application pending·0 cites
- 1661US2022144969A1Methods for reducing cardiovascular riskSANOFI BIOTECHNOLOGY·Filed 2021·Application pending·0 cites
- 1760US2020061189A1Methods for Treating Patients with Familial HypercholesterolemiaREGENERON PHARMA·Filed 2019·Application pending·0 cites
- 1857US2017296657A1Methods for Treating Hypercholesterolemia and Reducing LDL-C Using Antibodies to PCSK9REGENERON PHARMA·Filed 2017·Application pending·0 cites
- 1955US2015182515A1Methods for treating obesity and disorders associated with hyperlipidemia in a mammalAEGERION PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2053US2018296672A1Methods for Treating Patients with Hypercholesterolemia that is not Adequately Controlled by Moderate-Dose Statin TherapyREGENERON PHARMA·Filed 2018·Application pending·0 cites
- 2153US2007197442A1Methods for the Treatment of Macular Degeneration and Related Eye ConditionsPRESSLER MILTON L·Filed 2007·Application pending·0 cites
- 2253US2017312359A1Methods for treating patients with familial hypercholesterolemiaREGENERON PHARMA·Filed 2017·Application pending·0 cites
- 2352US2007254832A1Methods for the treatment of macular degeneration and related eye conditionsPRESSLER MILTON L·Filed 2007·Application pending·0 cites
- 2452US2018244801A1Methods for inhibiting atherosclerosis by administering an inhibitor of pcsk9REGENERON PHARMA·Filed 2018·Application pending·0 cites
- 2552US2014148476A1Methods for treating obesity and disorders associated with hyperlipidemia in a mammalAEGERION PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2651US2014356370A1Methods for treating autosomal dominant hypercholesterolemia associated with pcsk9 gain-of-function mutationsREGENERON PHARMA·Filed 2014·Application pending·0 cites
- 2751US2024366625A1Compositions containing and therapies using bempedoic acid and tolvaptanESPERION THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2850US2020024364A1Dosing regimens for use with pcsk9 inhibitorsSANOFI BIOTECHNOLOGY·Filed 2019·Application pending·0 cites
- 2949US2012035204A1Methods for Treating Obesity and Disorders Associated with Hyperlipidemia in a MammalSASIELA WILLIAM J·Filed 2011·Application pending·0 cites
- 3049US2015231236A1Methods for treating patients with hypercholesterolemia that is not adequately controlled by moderate-dose statin therapyREGENERON PHARMA·Filed 2015·Application pending·0 cites
- 3143US2019292273A1Methods for reducing cardiovascular riskSANOFI BIOTECHNOLOGY·Filed 2019·Application pending·0 cites
- 3243US2015140002A1Use of a pcsk9 inhibitor to treat hyperlipidemiaSANOFI SA·Filed 2014·Application pending·0 cites
- 3335US2015284473A1Methods for reducing cardiovascular riskBESSAC LAURENCE·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when William J. Sasiela files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →